secwatch.observer — SEC 8-K summary
======================================

Issuer:     Beyond Air, Inc. (XAIR)
CIK:        0001641631
Form:       8-K
Filed at:   2025-11-14T23:59:59+00:00
Accession:  0001493152-25-023538
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Beyond Air Q2 revenue up 128% to $1.8M; net loss narrows; secures $32M financing
--------------------------------------------------------------------------------

- Revenue $1.8M (+128% YoY); net loss ($7.9M) ($1.25/share) vs. ($13.4M) ($5.67/share).
- Secured $32M capital ($12M note, 15%, 24-month maturity + $20M equity line); proforma cash $22.9M, runway into 2027.
- Appointed Bob Goodman (Board member) as Interim CCO; David Webster departed.
- Updated FY2026 revenue guidance to $8-$10M; achieved MDSAP certification; patent allowance for Gen2 LungFit PH.
- International distribution network expanded to 35 countries; Phase 1a UNO trial completed with median survival >23 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641631/000149315225023538/0001493152-25-023538-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641631/000149315225023538/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-023538

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer